Published within
|«
«
|
...
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
10
|
...
|
»
»|
| Type |
Product title / description
|
Pub
|
Price |
Report
|
Overview of the current biomarkers used in rheumatology clinical practice. This report provides an assessment of emerging biomarkers, commercialization issues and the expected future impact on the market, supported by key opinion leader insight.
Published By Datamonitor
|
17 Dec 2009 |
$3800
|
Report
|
Datamonitor surveyed 183 rheumatologists in the seven major markets to gain insight into rheumatoid arthritis diagnosis, patient segmentation, current and future prescribing patterns, factors influencing decision making and key treatment challenges.
Published By Datamonitor
|
17 Sep 2010 |
$15200
|
Report
|
Datamonitor surveyed 180 primary care physicians and rheumatologists in the seven major markets to gain insight into osteoarthritis diagnosis, patient segmentation, current treatment options, unmet needs and late-stage pipeline drugs.
Published By Datamonitor
|
04 Dec 2009 |
$15200
|
Report
|
Primary research-based analysis of the non-Hodgkin's lymphomas market, including epidemiology, patient segmentation, and treatment data. Separate coverage of diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL).
Published By Datamonitor
|
17 Dec 2009 |
$15200
|
Report
|
Primary research-based analysis of the major depressive disorder market, based on a survey of 180 psychiatrists in the US, Japan, and EU. Includes epidemiology, patient segmentation, treatment trends, perception of key brands, and patient outcomes.
Published By Datamonitor
|
23 Dec 2010 |
$15200
|
Report
|
China, Taiwan, South Korea and Turkey represent highly endemic areas for viral Hepatitis, but little is known about therapy dynamics and drivers of treatment choice. Particularly in China, a high emphasis on efficacy as well as cost leads to continued use of inexpensive, but suboptimal treatment approaches. For this report, 180 high-prescribing physicians where surveyed in these countries, providing a breakdown of patients numbers, frequently prescribed regimens and brand perceptions.
Published By Datamonitor
|
15 Feb 2010 |
$15200
|
Report
|
Explores key issues in the gastric cancer market, including diagnosis and treatment patterns, specific drug regimens used at each line of therapy, key prescribing influences and predicted performance of late-phase pipeline products.
Published By Datamonitor
|
15 Sep 2010 |
$15200
|
Report
|
Primary research-based analysis of the epilepsy market, based on a survey of 180 neurologists in the US, Japan, and EU. Includes epidemiology, patient segmentation, treatment trends, perception of key brands, and patient outcomes.
Published By Datamonitor
|
16 Dec 2010 |
$15200
|
Report
|
Datamonitor surveyed 180 oncologists, anesthetists, palliative medicine specialists and pain care specialists in the seven major markets to gain insight into cancer pain prevalence, treatment trends and key prescribing influences.
Published By Datamonitor
|
23 Dec 2009 |
$15200
|
Report
|
Primary research-based analysis of the hormone receptor-positive breast cancer market. Includes epidemiology, patient segmentation, treatment trends, and future treatment scenarios. Separate coverage of triple-negative and HER-2-positive subsets.
Published By Datamonitor
|
03 Nov 2010 |
$15200
|
|«
«
|
...
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
10
|
...
|
»
»|
No help is available.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Business Insight reports are an objective source of data, analysis and market insight
Insight for technology vendors into customer trends and pain points from key business decision makers.
Butler Group's thought leadership, opinion, with end user case studies and product profiles for key vendors.
Butler Group's vendor ranking and assessment model groups vendors into Outperform, Perform, and Under-perform categories.
Butler Group's thought leadership, opinion, and best practice with technology audits, product comparisons and rankings.
Opinion and market commentary from Datamonitor's industry experts.
Company profiles deliver detailed insight into how companies are organized and function with SWOT analysis.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Opinion and market commentary from Datamonitor's industry experts.
Track industry events, markets, products, customers, prospects, competitors and partners
Country profiles presenting easy-to-digest summaries and standardized data.
Databooks use charts and tables to provide a data-centric view of a particular market or category
Opinion and market commentary from Datamonitor's industry experts.
Comprehensive category data, including market value, volume, segmentation and share, with analysis.
Industry profiles provide standardized market data (including size & segmentation) and competitive analysis.
Market sizing and forecast data for a market or sector delivered in spreadsheet format.
Track industry events, markets, products, customers, prospects, competitors and partners
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Opinion and market commentary from Datamonitor's industry experts.
Insight for technology vendors into customer trends and pain points from key business decision makers.
Business information covering a specific market or issue.